Literature DB >> 26691785

Comparison of three different posterior fixation techniques in transforaminal lumbar interbody fusion for two-level lumbar degenerative diseases: At a mean follow up time of 46 months.

Fubing Liu1, Yuanwu Cao1, Zhenzhou Feng1, Xiaogang Zhou1, Chun Jiang1, Xilei Li1, Zixian Chen1, Zheng Li1, Yun Liang1, Xiaoxing Jiang2, Jian Dong3.   

Abstract

OBJECTIVES: This study sought to retrospectively compare three different posterior fixation techniques in transforaminal lumbar interbody fusion for two-level lumbar degenerative diseases. PATIENTS AND METHODS: This was a retrospective single-center study including 84 patients who underwent TLIF instrumented with unilateral pedicle screws (UPS), unilateral pedicle screws plus contra-lateral translaminar facet screws (UPSFS), or bilateral pedicle screws (BPS) between June 2008 and May 2012. These patients were divided into three groups: UPS (n=22), UPSFS (n=28) and BPS (n=34) group. Operative time, blood loss, length of hospital stay, hospital bill, fusion status and complications were recorded and analyzed statistically. Visual analog scale (VAS), Oswestry Disability Index (ODI), and Japanese Orthopaedic Association Scores (JOA) were used to assess the preoperative and postoperative pain and functional outcome. Sagittal alignment was evaluated by the segment lordosis (SL) and whole lumbar spine lordosis (LL).
RESULTS: The mean follow up duration was 46.2 (ranging from 36 to 60) months. A significant decrease occurred in operative time, blood loss and hospital bill in UPS and UPSFS group, compared with BPS group (p<0.05). The average postoperative VAS, ODI and JOA scores improved significantly in each group than the preoperative counterparts (p<0.05), however, there were no significant difference between groups at any follow-up time point (p>0.05). No statistically difference was detected regarding fusion rate and complication rate between groups (p>0.05), except the screw/rod failure rate (p<0.05). Radiographic analysis showed that the LLs in all these groups got improved (p<0.05) and the SLs maintained (p>0.05).
CONCLUSION: UPS or UPSFS instrumented TLIF could achieve satisfactory mid-term clinical outcome comparable to BPS's, with less surgical time, less blood loss, and lower cost; UPS should be prudently performed for two-level cases in case of lower fusion rate, and cannulated screws should be replaced by stronger solid screws in UPSFS to reduce facet screw breakage.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Fixation; Lumbar degenerative diseases; Posterior; Transforaminal lumbar interbody fusion; Two-level

Mesh:

Year:  2015        PMID: 26691785     DOI: 10.1016/j.clineuro.2015.12.002

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  4 in total

1.  Transforaminal Lumbar Interbody Fusion with Rigid Interspinous Process Fixation: A Learning Curve Analysis of a Surgeon Team's First 74 Cases.

Authors:  Patrick Doherty; Arthur Welch; Jason Tharpe; Camille Moore; Chris Ferry
Journal:  Cureus       Date:  2017-05-30

2.  A Comparison Study of Three Posterior Fixation Strategies in Transforaminal Lumbar Interbody Fusion Lumbar for the Treatment of Degenerative Diseases.

Authors:  Yong Hu; Bing-Ke Zhu; Christopher K Kepler; Zhen-Shan Yuan; Wei-Xin Dong; Xiao-Yang Sun
Journal:  Indian J Orthop       Date:  2019 Jul-Aug       Impact factor: 1.251

3.  Anatomic study of the lumbar lamina for safe and effective placement of lumbar translaminar facet screws.

Authors:  Yong Hu; Bing-Ke Zhu; Zhen-Shan Yuan; Wei-Xin Dong; Xiao-Yang Sun; Jian-Zhong Xu; Xu-Guo Chen
Journal:  J Int Med Res       Date:  2019-08-27       Impact factor: 1.671

4.  Prevalence and risk factors for cage subsidence after lumbar interbody fusion: A protocol for systematic review and meta-analysis.

Authors:  Qiujiang Li; Xingxia Long; Lin Shi; Yinbin Wang; Tao Guan; Jinhan Lv; Lijun Cai
Journal:  Medicine (Baltimore)       Date:  2021-12-10       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.